Help Optimize Antiplatelet Meds After an Ischemic Stroke

July 2026

About 1 in 4 ischemic stroke survivors will suffer another stroke...and you can help ensure they get proper meds for prevention.

Expect antiplatelet therapy to depend on stroke severity and bleeding risk.

For example, you’ll likely see dual antiplatelet therapy (DAPT) up front for milder strokes (NIH Stroke Scale ≤5) or high-risk transient ischemic attacks (ABCD² score ≥4) that have lower bleeding risk.

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Prescriber Insights: APRN includes:

Cutting-edge advice about new medications and how they fit into practice
Unbiased, evidence-based, 100% free of financial support from the pharma industry written by your peers
Side-by-side comparisons of drugs by class or disease state, plus FAQs, pros/cons, and simple recommendations

Subscribe Today!

Already a subscriber? Log in

Volume pricing available. Get a quote

GLP-1 Agonists Navigate Questions About the Medicare GLP-1 Bridge
Lyme Disease Brush Up on Tick Bites and Preventing Lyme Disease
Rumor vs Truth Flush Out the Truth Behind Common Laxative Claims
Stroke Help Optimize Antiplatelet Meds After an Ischemic Stroke
Fall Risk Be Ready With Practical Strategies for Fall Prevention
Cholesterol How Does Lerodalcibep Compare to Other PCSK9 Inhibitors?
Allergic Reactions Know How to Manage Reported Local Anesthetic Allergies
Ophthalmology Sharpen Focus on Rx Presbyopia Eye Drops

Help Optimize Antiplatelet Meds After an Ischemic Stroke

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Table of Contents